The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study.
Saved in:
| Title: | The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study. |
|---|---|
| Authors: | Chen Y; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Luo J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Chen J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Kotlyar E; St. Vincent's Hospital, Sydney, NSW, Australia., Li Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Chen W; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China., Li J; Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Jan 12; Vol. 12, pp. 811700. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2021.811700 |
